Abbott launches Amplatzer Piccolo in India for the treatment of heart defects in premature babies
Mumbai, 15 June 2021:
On Tuesday, Abbott announced the launch of Amplatzer Piccolo Occluder in India, the world’s first medical device that can be transplanted into the smallest babies using minimally invasive surgery to treat patent ductus arteriosus (PDA).
The Amplatzer Piccolo Occluder is a self-expanding wire mesh device that is inserted through a small incision in the leg, guided through a blood vessel to the heart, and placed to seal the opening in the heart. Not only is it designed for doctors to insert through the aorta or pulmonary artery, it also allows the device to be removed and repositioned for optimal placement. Because the device is deployed in minimally invasive surgery, many severely ill premature babies in the neonatal intensive care unit can withdraw from mechanical ventilation support shortly after surgery.
“Piccolo is an important advance in standard treatment for the most vulnerable premature babies who may not be able to undergo surgery to repair the heart,” said Abbott’s structural heart business general in India and the subcontinent. Manager Payal Agrawal said. “We are passionate about developing life-changing technologies so that people, including vulnerable babies, can lead better lives. Through our devices, these children are normal. I am happy to know that I have the opportunity to live a life and that I can live the maximum life. “
Amplatzer Piccolo, an even smaller device than peas, is now giving hope to premature babies and newborns who need orthodontic treatment, may not respond to the drug, and are at high risk of undergoing orthodontic surgery. did.
Dr. Edwin Francis, Senior Consultant, Department of Pediatric Cardiology, Lisie Hospital, Ernakulam, said: He added: “This is a great preload device. It doesn’t require a lot of preparation and has a soft profile that is easy to deploy. It’s more versatile in terms of size, so it’s suitable for babies of different ages and weights. It is suitable.”
About 3.5 million premature babies are born each year in India, and the birth weight is very low. Incidence of PDA ranges from 15% to 37% in newborns weighing less than 1750 grams. Overall, PDAs make up 5% to 10% of all congenital heart diseases, and the prevalence of “symptomatic” PDAs is 0.5 / 1000 births. This means that the PDA is large, causes symptoms, and requires treatment for the baby to survive.
Abbott launches Amplatzer Piccolo in India for the treatment of heart defects in premature babies, Health News, ET HealthWorld